| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study
|
Bao, Hejing
|
|
|
149 |
3 |
p. 1185-1193
|
artikel
|
| 2 |
Antibiotic therapy is associated with an increased incidence of cancer
|
Roderburg, Christoph
|
|
|
149 |
3 |
p. 1285-1293
|
artikel
|
| 3 |
Anti-PD-1-based immunotherapy plus lenvatinib to treat advanced gallbladder cancer in the elderly: a case series and review of current literature
|
Wang, Lantian
|
|
|
149 |
3 |
p. 941-950
|
artikel
|
| 4 |
A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome
|
DiNardo, Courtney D.
|
|
|
149 |
3 |
p. 1145-1158
|
artikel
|
| 5 |
A propensity score–matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer
|
Magnoni, Francesca
|
|
|
149 |
3 |
p. 1085-1093
|
artikel
|
| 6 |
A virtual dance sport class for cancer patients: the trainer perspective
|
Keinki, Christian
|
|
|
149 |
3 |
p. 1079-1083
|
artikel
|
| 7 |
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
|
Stefoni, Vittorio
|
|
|
149 |
3 |
p. 1043-1047
|
artikel
|
| 8 |
Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study
|
Larsen, Solveig Kärk Abildtrup
|
|
|
149 |
3 |
p. 1221-1230
|
artikel
|
| 9 |
Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data
|
Forner, Dirk Michael
|
|
|
149 |
3 |
p. 1115-1122
|
artikel
|
| 10 |
Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis
|
Krishnan, Sabareeswaran
|
|
|
149 |
3 |
p. 951-967
|
artikel
|
| 11 |
Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC
|
Liang, Xiao
|
|
|
149 |
3 |
p. 1211-1220
|
artikel
|
| 12 |
Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis
|
Wen, Wen
|
|
|
149 |
3 |
p. 969-978
|
artikel
|
| 13 |
Comparison of clinical characteristics, treatment efficacy and survival in patients with newly diagnosed multiple myeloma with single- versus multi-site extramedullary invasion
|
Zhao, Yongfeng
|
|
|
149 |
3 |
p. 995-1006
|
artikel
|
| 14 |
Correction: LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway
|
Shi, Wenjing
|
|
|
149 |
3 |
p. 1355
|
artikel
|
| 15 |
Correlation analysis between androgen receptor and the clinicopathological features and prognosis of mammary Paget’s disease
|
Wu, Yang
|
|
|
149 |
3 |
p. 1175-1184
|
artikel
|
| 16 |
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers
|
Ortmann, O.
|
|
|
149 |
3 |
p. 1195-1209
|
artikel
|
| 17 |
Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study
|
Kolbe, Katharina
|
|
|
149 |
3 |
p. 1319-1329
|
artikel
|
| 18 |
Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors
|
Gambichler, T.
|
|
|
149 |
3 |
p. 1241-1247
|
artikel
|
| 19 |
Gastric cancer in the pediatric population, a multicenter cross-sectional analysis of presentation and coexisting comorbidities
|
Attard, Thomas M.
|
|
|
149 |
3 |
p. 1261-1272
|
artikel
|
| 20 |
Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer
|
Krause, Alina
|
|
|
149 |
3 |
p. 1231-1240
|
artikel
|
| 21 |
Immune checkpoint inhibitors’ combination therapy as first-line treatment in advanced esophageal squamous cell carcinoma: a meta-analysis
|
Li, Dianhe
|
|
|
149 |
3 |
p. 933-939
|
artikel
|
| 22 |
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer
|
Matsubara, Yuki
|
|
|
149 |
3 |
p. 1123-1129
|
artikel
|
| 23 |
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer
|
Shimozaki, Keitaro
|
|
|
149 |
3 |
p. 1273-1283
|
artikel
|
| 24 |
LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway
|
Shi, Wenjing
|
|
|
149 |
3 |
p. 1295-1311
|
artikel
|
| 25 |
Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis
|
Stolze, T.
|
|
|
149 |
3 |
p. 1007-1017
|
artikel
|
| 26 |
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis
|
De Virgilio, Armando
|
|
|
149 |
3 |
p. 1029-1041
|
artikel
|
| 27 |
Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer
|
Du, Wei
|
|
|
149 |
3 |
p. 1103-1113
|
artikel
|
| 28 |
Patient characteristics and preferences for a surgical prehabilitation program design: results from a pilot survey
|
Gurunathan, Usha
|
|
|
149 |
3 |
p. 1361-1367
|
artikel
|
| 29 |
Pembrolizumab for all
|
Kim, Myung S.
|
|
|
149 |
3 |
p. 1357-1360
|
artikel
|
| 30 |
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study
|
Jansen-Winkeln, B.
|
|
|
149 |
3 |
p. 1331-1341
|
artikel
|
| 31 |
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse
|
Hoffmann, Oliver
|
|
|
149 |
3 |
p. 1159-1174
|
artikel
|
| 32 |
Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis
|
Zhang, Shuwen
|
|
|
149 |
3 |
p. 1063-1077
|
artikel
|
| 33 |
Reply to Letter to the Editor regarding “Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‐)radiotherapy: a systematic review and meta‐analysis”
|
De Virgilio, Armando
|
|
|
149 |
3 |
p. 1369-1371
|
artikel
|
| 34 |
Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies
|
Kleo, Karsten
|
|
|
149 |
3 |
p. 1049-1061
|
artikel
|
| 35 |
Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis
|
Ehret, Felix
|
|
|
149 |
3 |
p. 1095-1101
|
artikel
|
| 36 |
Roles of circular RNAs in regulating the development of glioma
|
Fan, Jianing
|
|
|
149 |
3 |
p. 979-993
|
artikel
|
| 37 |
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen
|
Beom, Seung-Hoon
|
|
|
149 |
3 |
p. 1131-1143
|
artikel
|
| 38 |
Study protocol: the OptiScreen-Study: optimized psycho-oncological care—from screening to intervention
|
Zimmermann, Tanja
|
|
|
149 |
3 |
p. 1343-1354
|
artikel
|
| 39 |
Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer
|
Liu, Yu-Ying
|
|
|
149 |
3 |
p. 1249-1259
|
artikel
|
| 40 |
The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients
|
Wu, Guowu
|
|
|
149 |
3 |
p. 1019-1028
|
artikel
|
| 41 |
The survival analysis and feasibility study of Pars Plana Vitrectomy (PPV) in the treatment of retinoblastoma
|
Mou, Jianing
|
|
|
149 |
3 |
p. 1313-1318
|
artikel
|
Tijdschrift beschrijving